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Saline Water Conversion Corporation (SWCC) is the main source of water in the Red Sea
coast in Jeddah, KSA, the workers and their families are exposed to vapor and chemicals that
affect their upper respiratory tract.
Our aim was to study the prevalence of unified airway disease [allergic rhinitis (AR) and
bronchial asthma] in SWCC Society accommodations, serum immunoglobulin E (IgE)
level and its relation to the duration of bronchial asthma, and duration of living in the
accommodations.

Patients and methods

This randomized study included 400 patients with bronchial asthma, the included patients
comprised two groups: group I (GI) (n=200) from SWCC Society accommodations and
group II (GII) (n=200) patients from outside the accommodations.
Both groups were classified according to Allergy Classification of allergic rhinitis and its impact
on asthma and blood samples for IgE taken from them.

Results

According to the classification of allergic rhinitis and its impact on asthma, the persistent and
moderate–severe allergy were more common in GI (80%) and the intermittent allergy and
mild severity was 20%, while the persistent and moderate–severe allergy were less common
in GII (22%) and the intermittent allergy and mild severity was 78%.
GI patients experienced a significantly high IgE level compared with GII, higher in males
than females, and increases with the duration of living in the accommodations and duration
of bronchial asthma.

Conclusion

Unified airway disease is common in SWCC Society with a high level of IgE compared with
outside the accommodations.
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Introduction
Allergic rhinitis (AR) is affecting 10–20% of the
population, and evidence suggests that the incidence
of the disorder is increasing [1,2]. Severe AR has been
associated with significant impairments in quality of
life, sleep, and work performance [3].

Occupational rhinitis
Occupational rhinitis is understood as inflammatory
disease of the nose with intermittent or persistent
symptoms than nasal obstruction, nasal secretion,
sneezing, and pruritus when exposed to a particular
work environment and not to stimuli outside the
workplace [4]. The prevalence of occupational rhinitis
is hidden maybe due to high‑risk professions, including
laboratory or food‑processing workers, farmers, and
workers in various industries [5]. Occupational rhinitis
commonly occurs in the first 3 years of employment.

It is to be immunoglobulin E (IgE)‑mediated due to
allergen sensitization, or due to exposure to respiratory
irritants. Some studies suggest that occupational
rhinitis will progress to occupational asthma with time
of exposure [6,7].

Occupational bronchial asthma
Workers in various industries and occupations are at
risk for work‑related asthma [8]. Data from the 2005
to 2008 adult Asthma Call‑Back Survey, in asthma
survey conducted with respondents who report an
asthma diagnosis, from 35 states, indicated that up to
49% of adult current asthma might be related to work
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and could be prevented [9]. At the time of the survey,
they were employed or had been out of work for less
than 14 months. Among these respondents, 7.8% had
current asthma; based on the Asthma Call‑Back Survey
results, optional asthma modules can be used to identify
industries and occupations to assess for asthma among
workers, identify workplace exposures, and guide the
design and evaluation of effective work‑related asthma
prevention and education programs [10].

Blood sample collection: an ELISA kit,
Human Diagnostics (Germany, catalog number #
51005, Jeddah), was used for total IgE measurement.The
test used the WHO IgE standards to be a benchmark.

Unified airway disease, the one‑airway, one‑disease
hypothesis proposes that the upper and lower airways
share the same physiology and histomorphology [11].

Statistical analysis

In our study, we will compare the IgE level in both
groups according to different durations of occupational
exposure and those of asthma.

Saline Water Conversion Corporation (SWCC)
could be a Saudi Company Corporation to blame for
desalinating ocean water, for offering of potable water
to cities within the kingdom [12,13].

The results of the present study were presented as
number and percent or mean and SDs. Numerical
data were compared using t test, while categorical data
were compared using χ2 test. All statistical calculations
were achieved using SPSS 25 (IBM, Chicago, Illinois,
USA). P value less than 0.05 was considered statistically
significant.

Patients and methods
The present randomized study was conducted at a
private hospital in Jeddah, Kingdom of Saudi Arabia.
The study protocol was approved by the local ethical
committee and all patients gave informed consent before
participation. The study included group I (GI) (n=200)
patients diagnosed as bronchial asthma, from SWCC
Society accommodations, and group II (GII) (n=200)
patients diagnosed as bronchial asthma outside the
SWCC Society accommodations.

Results
The present study includes 400 patients with bronchial
asthma; GI from SWCC Society accommodations
were 200, their age ranged from 16 to 59 years,
72 females and 128 males (test group) and GII,
200 patients outside accommodations had bronchial
asthma with AR with age that ranged from 17 years
up to 60 years, 78 females and 122 males (control
group), both groups diagnosed as AR according to
AIRA classification.

Inclusion criteria: the patients were diagnosed as
bronchial asthma after clinical examination and
pulmonary function test, including forced expiratory
volume in 1 s, forced vital capacity, peak expiratory
flow, and airway hyperresponsiveness, without any
other pulmonary diseases.

Figure 1 showed the prevalence of unified airway in
GI (64.31%), while in GII was 31.84%.

All the patients were subjected to complete history
and examination to exclude any other types of allergy,
except for nasal symptoms for AR.
The clinical history of AR includes continual excessive
sneezing, nasal itching, nasal discharge, or nasal
congestion or obstruction.
Exclusion criteria: enclosed current steroids and/
or antihistamine ingestion and the presence of
skin‑allergic reaction.
Fibro‑optic examination is done for all patients
demonstrating pale and edematous nasal mucosa,
watery nasal discharge, and swollen inferior turbinates.
The patients diagnosed as AR are classified according
to allergic rhinitis and its impact on asthma (AIRA)
classification (Table 1).

Table 2 showed values for total IgE plasma levels (IU/
ml) between the studied groups according to AIRA
classification; in test GI, was significant, intermittent
patients (162.3±92.0), persistent (283.9±133.9),
and mild severity (412.3±231.6) and moderate/
severe (609+338.5) versus control GII intermittent
patients
(76.6±47.2),
persistent
(158±86.8),
and mild severity (215.7±135) and moderate/
severe (325.0±195.0) (P<0.0001) [Table 2].
Figure 2 showed that males are superior to females
as regards mean total IgE (IU/ml) level in both
Table 1 Classification of allergic rhinitis and its impact on
asthma
Classification Definition
Intermittent
Persistent
Mild severity

Symptoms <4 days/week or <4 consecutive weeks
Symptoms >4 days/week or >4 consecutive weeks
No sleep disturbance, no impairment of daily
activities, and symptoms present but not troublesome

Moderate/
severe

Sleep disturbance, impairment of daily activities, and
troublesome symptoms
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Table 2 Mean values of total immunoglobulin E plasma levels in patients with allergic rhinitis according to allergic rhinitis and
its impact on asthma classification
Group I [n (%)]

Mean IgE

Group II [n (%)]

Mean IgE

P

Intermittent
Persistent
Mild severity

12 (6)
100 (50)
28 (14)

162.3±92.0
283.9±133.9
412.3±231.6

72 (36)
16 (8)
88 (44)

76.6±47.2
158±86.8
215.7±135.1

<0.0001
<0.0001
<0.0001

Moderate/severe

60 (30)

609 + 338.5

24 (12)

325.0 ± 195.0

<0.0001

IgE, immunoglobulin E.
Table 3 Mean values of total immunoglobulin E plasma
levels in patients with allergic rhinitis according to bronchial
asthma duration
Bronchial asthma duration

Group I

Group II

Figure1

P

1-2 years
2-4 years
4-6 years

261.0±152.0 160.1±115.0 <0.0001
488.0±190.0 201.7±123.0 <0.0001
543.0±0.310.0 250.2±144.0 <0.0001

Above 6 years

609.7 ± 385.0 292.6 ± 186.0 <0.0001

groups (413.0±143.0 vs. 293.9±108.0) (P<0.0001),
and also as regards the group of age up to 30 years
and group above 30 years in both groups (P<0.0001),
while there was no significant difference in the mean
age (32.2±22.8 vs. 39.2±27.8) (P>0.05).
Table 3 showed mean values of total IgE plasma
levels (IU/ml) in patients with AR according to
bronchial asthma duration. In patients with bronchial
asthma (1–2 years), GI was 160.1±115.0 versus
261.0±152.0, in GII, in patients with bronchial asthma
2–4 years, GI 201.7±123.0 versus 488.0±190.0 in GII,
and in the group with duration 4–6 years, GI was
250.2±144.0 versus GII 543.0±0.310.0 and in duration
above 6 years, GI 292.6±186.0 versus 609.7±385.0
in GII, the difference between GI and GII was
significant (P<0.0001).
Figure 3 showed that there is a significant increase in
IgE level in the test group with more years living in
accommodations of the SWCC Society (231.0±132.0,
428.0±180.0,
and
513.0±0.298.0
vs.
590.7±375.0) (P<0.0001).

Discussion
The relation between AR and asthma has been reported
in the literature [14]. There is a considerable variation in
the observed prevalence of AR in patients with asthma
globally, with a nearly 55% prevalence being reported
in the United States and Europe. Also, there was high
prevalence in the International Study of Asthma and
Allergies in Childhood conducted in 56 countries [15].
Our study showed that males have a higher prevalence
of unified airway disease as compared with females
in all patients. Similar results were seen in a Finnish
study [16], where the risk of AR was significantly

Prevalence of unified airway disease in both groups.

higher in males than in females, which agrees with
Tsao et al. [17] who concluded the same results due to
exposing to pollution in industries more in males.
The aim of this study was to determine whether total
IgE plasma levels differed between bronchial asthma
patients with AR from SWCC accommodations
and the control group outside the accommodation.
Antibodies belonging to the test group are produced in
response to allergenic environmental stimuli and their
concentrations and specificities are strongly associated
with various manifestations of allergies; our results
are in agreement with other studies that evaluated
IgE level in Brazilian people according to age and
environmental effects [18].
In our study, we concluded that the persistent AR and
moderate–severe type according to AIRA classification
are more in the bronchial asthma patients with AR
from SWCC accommodations, while it was less in
number in patients with AR from outside SWCC
accommodation, which agrees with Park [19] who
concluded that smoke and industrial pollution are
known risk factors that increase the prevalence of
respiratory diseases.
Moreover, our study concluded that in SWCC
accommodations, people are exposed to air pollution
as waste products of the machines use fuel to work,
which predisposes to AR and bronchial asthma with
duration of exposure that is higher, which agrees with
studies that concluded that in China, the number of
asthma cases increased rapidly since the early 2000s.
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Figure2

Figure3

Mean IgE levels according to duration of living in accommodations.
IgE, immunoglobulin E.
IgE level between males and females and age groups. IgE,
immunoglobulin E.

Conflicts of interest

Researchers have published several epidemiologic
studies on the association between ambient pollutants
and asthma prevalence [20].
In addition, our study noted that the effect of diesel
fuel and carbon increases the rate of AR in bronchial
asthma patients and total IgE level increases with the
duration of living in SWCC accommodations, which
agrees with studies that concluded that occupational
nasal allergy with asthma (OA) is often underdiagnosed
and underreported, and if unrecognized, can lead to
progression of disease and increased morbidity [21].
Sensitizers to occupational asthma are of two
types: high‑molecular‑weight compounds and
low‑molecular‑weight compounds [22]. The most
common causes of unified airway disease are
agents that include floor dust, enzymes (plant‑and
animal‑derived), gums, foods, tobacco, rubber‐derived
proteins, insect‐derived allergens, acid anhydrides,
metals, and a spectrum of chemical substances.
Diagnosis of bronchial asthma has an effect on the
future employment and health, but this should be
considered to keep in mind that a careful history of
work‐related exposures is included in evaluation of a
patient with chronic cough, asthma, and AR.

Conclusion
Unified airway disease is common in SWCC with
a high level of IgE compared with outside the
accommodations.
IgE levels are higher in males than females, increased
with a long duration living in the accommodation,
and increased with a long‑duration history of
asthma.
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